相似文献
1
Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.
Br J Cancer. 1987 Dec;56(6):800-2. doi: 10.1038/bjc.1987.293.
2
Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2.
Int J Cancer. 1986 Mar 15;37(3):343-9. doi: 10.1002/ijc.2910370304.
3
Nature of the T lymphocytes in lymphocyte predominance Hodgkin's disease.
Leuk Lymphoma. 1997 Feb;24(5-6):545-51. doi: 10.3109/10428199709055592.
4
The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
Br J Cancer. 2001 May 18;84(10):1339-43. doi: 10.1054/bjoc.2001.1792.
5
Surface receptors involved in human T lymphocyte activation.
Mt Sinai J Med. 1986 Mar;53(3):210-5.
6
Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
J Immunol. 1984 Apr;132(4):1833-6.
7
T cell activation antigens: therapeutic implications.
Immunol Invest. 1987;16(8):687-723. doi: 10.3109/08820138709087109.
8
Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
Cancer. 1980 Feb 15;45(4):767-74. doi: 10.1002/1097-0142(19800215)45:4<767::aid-cncr2820450426>3.0.co;2-4.
9
Letter: Lymphocytes in spleen in Hodgkin's disease.
Lancet. 1975 Feb 8;1(7902):332-3. doi: 10.1016/s0140-6736(75)91238-6.
10
Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
Transplantation. 1986 Sep;42(3):317-20.
引用本文的文献
1
Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.
PLoS One. 2015 Sep 25;10(9):e0138747. doi: 10.1371/journal.pone.0138747. eCollection 2015.
2
Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
Br J Cancer. 1990 Aug;62(2):205-8. doi: 10.1038/bjc.1990.261.
3
Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.
Br J Cancer. 1990 Mar;61(3):404-6. doi: 10.1038/bjc.1990.88.
4
本文引用的文献
1
Demonstration of inhibitory factors affecting cell-mediated immunity in patients with Hodgkin's disease.
Eur J Cancer (1965). 1980 Jul;16(7):937-43. doi: 10.1016/0014-2964(80)90332-1.
2
3
4
Subpopulations of human T lymphocytes. XIV. Abnormality of T-cell locomotion and of distribution of subpopulations of T and B lymphocytes in peripheral blood and spleen from children with untreated Hodgkin's disease.
Clin Immunol Immunopathol. 1980 Feb;15(2):133-43. doi: 10.1016/0090-1229(80)90026-4.
5
Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential.
Acta Haematol. 1983;70(6):357-63. doi: 10.1159/000206793.
6
Subsets of blood, spleen and recirculating lymphocytes in man.
Clin Exp Immunol. 1983 Sep;53(3):672-8.
7
Evaluation of the circulating and splenic lymphocyte subpopulations in patients with non-Hodgkin lymphomas and Hodgkin's disease using monoclonal antibodies.
Blut. 1983 Jul;47(1):41-51. doi: 10.1007/BF00321049.
8
Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.
J Immunol. 1984 Dec;133(6):2996-3000.
9
Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
Clin Immunol Immunopathol. 1985 Apr;35(1):111-24. doi: 10.1016/0090-1229(85)90084-4.
10
Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
Eur J Cancer Clin Oncol. 1985 Aug;21(8):935-9. doi: 10.1016/0277-5379(85)90111-7.
Zotero 插件